During the past decade, Kumamoto University Medical School conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kumamoto University Medical School" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Kumamoto University Medical School" are "Brain Neoplasms" (1 trials), "Lymphoma, B-Cell" (1 trials) and "Neoplasm Metastasis" (1 trials). Many other conditions were trialed in "Kumamoto University Medical School" in a lesser frequency.

Most popular intervention types in "Kumamoto University Medical School" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab + Bi-weekly CHOP" (1 trials), "Rituximab + Standard CHOP" (1 trials), "Salvage stereotactic radiosurgery arm" (1 trials) and "Whole brain radiation therapy arm" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kumamoto University Medical School" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kumamoto University Medical School". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kumamoto University Medical School, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kumamoto University Medical School, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".